Developmental silencing and independency from E2F of apoptotic gene expression in postmitotic tissues

FEBS Letters

Volumn 581, Issue 30, 2007, Pages 5781-5786

  Zhang, Jisheng ^a   Bahi, Núria ^a   Zubiaga, Ana M ^b   Comella, Joan X ^a,c   Llovera, Marta ^a   Sanchis, Daniel ^a  

^a UNIVERSITY OF LLEIDA   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c INSTITUT DE NEUROCIÈNCIES   (Spain)

Author keywords

Apoptosis; Brain; Caspase; Development; E2F; Heart

Indexed keywords

CASPASE; TRANSCRIPTION FACTOR E2F1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; CELL CYCLE PROGRESSION; CELL DEATH; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HEART DEVELOPMENT; MALE; MITOSIS; NONHUMAN; PERINATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SIGNAL TRANSDUCTION;

EID: 36849083997     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.11.046     Document Type: Article

References (40)

1. Russell J.H., and Ley T.J. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20 (2002) 323-370
2. Stassi G., and De Maria R. Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat. Rev. Immunol. 2 (2002) 195-204
3. Tsujimoto Y., Cossman J., Jaffe E., and Croce C.M. Involvement of the bcl-2 gene in human follicular lymphoma. Science 228 (1985) 1440-1443
4. Jaattela M. Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene 23 (2004) 2746-2756
5. Ohno M., Takemura G., Ohno A., Misao J., Hayakawa Y., Minatoguchi S., Fujiwara T., and Fujiwara H. "Apoptotic" myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electron microscopy combined with in situ nick end-labeling. Circulation 98 (1998) 1422-1430
6. Knaapen M.W., Davies M.J., De Bie M., Haven A.J., Martinet W., and Kockx M.M. Apoptotic versus autophagic cell death in heart failure. Cardiovasc. Res. 51 (2001) 304-312
7. Donovan M., and Cotter T.G. Caspase-independent photoreceptor apoptosis in vivo and differential expression of apoptotic protease activating factor-1 and caspase-3 during retinal development. Cell Death Differ. 9 (2002) 1220-1231
8. Donovan M., Doonan F., and Cotter T.G. Decreased expression of pro-apoptotic Bcl-2 family members during retinal development and differential sensitivity to cell death. Dev. Biol. 291 (2006) 154-169
9. Bahi N., Zhang J., Llovera M., Ballester M., Comella J.X., and Sanchis D. Switch from caspase-dependent to caspase-independent death during heart development: essential role of endonuclease G in ischemia-induced DNA processing of differentiated cardiomyocytes. J. Biol. Chem. 281 (2006) 22943-22952
10. Yakovlev A.G., Ota K., Wang G., Movsesyan V., Bao W.L., Yoshihara K., and Faden A.I. Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury. J. Neurosci. 21 (2001) 7439-7446
11. Wright K.M., Linhoff M.W., Potts P.R., and Deshmukh M. Decreased apoptosome activity with neuronal differentiation sets the threshold for strict IAP regulation of apoptosis. J. Cell Biol. 167 (2004) 303-313
12. Stoka V., Turk V., and Bredesen D.E. Differential regulation of the intrinsic pathway of apoptosis in brain and liver during ageing. FEBS Lett. 580 (2006) 3739-3745
13. Madden S.D., Donovan M., and Cotter T.G. Key apoptosis regulating proteins are down-regulated during postnatal tissue development. Int. J. Dev. Biol. 51 (2007) 415-423
14. Han Y., Chen Y.S., Liu Z., Bodyak N., Rigor D., Bisping E., Pu W.T., and Kang P.M. Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition. Circ. Res. 99 (2006) 415-423
15. Potts M.B., Vaughn A.E., McDonough H., Patterson C., and Deshmukh M. Reduced Apaf-1 levels in cardiomyocytes engage strict regulation of apoptosis by endogenous XIAP. J. Cell Biol. 171 (2005) 925-930
16. Iglesias A., Murga M., Laresgoiti U., Skoudy A., Bernales I., Fullaondo A., Moreno B., Lloreta J., Field S.J., Real F.X., and Zubiaga A.M. Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice. J. Clin. Invest. 113 (2004) 1398-1407
17. Cigola E., Kajstura J., Li B., Meggs L.G., and Anversa P. Angiotensin II activates programmed myocyte cell death in vitro. Exp. Cell Res. 231 (1997) 363-371
18. Kang P.M., Haunstetter A., Aoki H., Usheva A., and Izumo S. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ. Res. 87 (2000) 118-125
19. Yang Y., and Yu X. Regulation of apoptosis: the ubiquitous way. FASEB J. 17 (2003) 790-799
20. Moroni M.C., Hickman E.S., Lazzerini Denchi E., Caprara G., Colli E., Cecconi F., Muller H., and Helin K. Apaf-1 is a transcriptional target for E2F and p53. Nat. Cell Biol. 3 (2001) 552-558
21. Furukawa Y., Nishimura N., Furukawa Y., Satoh M., Endo H., Iwase S., Yamada H., Matsuda M., Kano Y., Nakamura M., Furukawa Y., Nishimura N., Furukawa Y., Satoh M., Endo H., Iwase S., Yamada H., Matsuda M., Kano Y., and Nakamura M. Apaf-1 is a mediator of E2F-1-induced apoptosis. J. Biol. Chem. 277 (2002) 39760-39768
22. Pediconi N., Ianari A., Costanzo A., Belloni L., Gallo R., Cimino L., Porcellini A., Screpanti I., Balsano C., Alesse E., Gulino A., and Levrero M. Differential regulation of E2F1 apoptotic target genes in response to DNA damage. Nat. Cell Biol. 5 (2003) 552-558
23. Muller H., Bracken A.P., Vernell R., Moroni M.C., Christians F., Grassilli E., Prosperini E., Vigo E., Oliner J.D., and Helin K. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Gene Dev. 15 (2001) 267-285
24. Cao Q., Xia Y., Azadniv M., and Crispe I.N. The E2F-1 transcription factor promotes caspase-8 and bid expression, and enhances Fas signaling in T cells. J. Immunol. 173 (2004) 1111-1117
25. Nahle Z., Polakoff J., Davuluri R.V., McCurrach M.E., Jacobson M.D., Narita M., Zhang M.Q., Lazebnik Y., Bar-Sagi D., and Lowe S.W. Direct coupling of the cell cycle and cell death machinery by E2F. Nat. Cell Biol. 4 (2002) 859-864
26. Xie W., Jiang P., Miao L., Zhao Y., Zhimin Z., Qing L., Zhu W.G., and Wu M. Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1. Nucleic Acid Res. 34 (2006) 2046-2055
27. Gervais F.G., Xu D., Robertson G.S., Vaillancourt J.P., Zhu Y., Huang J., LeBlanc A., Smith D., Rigby M., Shearman M.S., Clarke E.E., Zheng H., Van Der Ploeg L.H., Ruffolo S.C., Thornberry N.A., Xanthoudakis S., Zamboni R.J., Roy S., and Nicholson D.W. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 97 (1999) 395-406
28. Nam Y.J., Mani K., Ashton A.W., Peng C.F., Krishnamurthy B., Hayakawa Y., Lee P., Korsmeyer S.J., and Kitsis R.N. Inhibition of both the extrinsic and intrinsic death pathways through non-homotypic death-fold interactions. Mol. Cell. 15 (2004) 901-912
29. Hermel E., Gafni J., Propp S.S., Leavitt B.R., Wellington C.L., Young J.E., Hackam A.S., Logvinova A.V., Peel A.L., Chen S.F., Hook V., Singaraja R., Krajewski S., Goldsmith P.C., Ellerby H.M., Hayden M.R., Bredesen D.E., and Ellerby L.M. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death Differ. 11 (2004) 424-438
30. Yoshida H., Kong Y.Y., Yoshida R., Elia A.J., Hakem A., Hakem R., Penninger J.M., and Mak T.W. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94 (1998) 739-750
31. Cecconi F., Alvarez-Bolado G., Meyer B.I., Roth K.A., and Gruss P. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 94 (1998) 727-737
32. Lakhani S.A., Masud A., Kuida K., Porter Jr. G.A., Booth C.J., Mehal W.Z., Inayat I., and Flavell R.A. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311 (2006) 847-851
33. Chen M., Won D.J., Krajewski S., and Gottlieb R.A. Calpain and mitochondria in ischemia/reperfusion injury. J. Biol. Chem. 277 (2002) 29181-29186
34. Hoglinger G.U., Breunig J.J., Depboylu C., Rouaux C., Michel P.P., Alvarez-Fischer D., Boutillier A.L., Degregori J., Oertel W.H., Rakic P., Hirsch E.C., and Hunot S. The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proc. Natl. Acad. Sci. USA 104 (2007) 3585-3590
35. van Empel V.P., Bertrand A.T., van der Nagel R., Kostin S., Doevendans P.A., Crijns H.J., de Wit E., Sluiter W., Ackerman S.L., and De Windt L.J. Downregulation of apoptosis-inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation. Circ. Res. 96 (2005) 92-101
36. Klein J.A., Longo-Guess C.M., Rossmann M.P., Seburn K.L., Hurd R.E., Frankel W.N., Bronson R.T., and Ackerman S.L. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 419 (2002) 367-374
37. Field S.J., Tsai F.Y., Kuo F., Zubiaga A.M., Kaelin Jr. W.G., Livingston D.M., Orkin S.H., and Greenberg M.E. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85 (1996) 549-561
38. DeGregori J., Leone G., Miron A., Jakoi L., and Nevins J.R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94 (1997) 7245-7250
39. Garcia I., Murga M., Vicario A., Field S.J., and Zubiaga A.M. A role for E2F1 in the induction of apoptosis during thymic negative selection. Cell Growth Differ. 11 (2000) 91-98
40. Lazzerini Denchi E., and Helin K. E2F1 is crucial for E2F-dependent apoptosis. EMBO Rep. 6 (2005) 661-668